We have shown that hBM-MSCs can restrain NADPH oxidase signaling pathway and reduced liver fibrosis in HSCs in mouse model of CCl4-induced liver injury; the role of this pathway in mouse model of CCl4-induced liver fibrosis was further investigated. Here, FMO5 is linked to Hepatic fibrosis.